imipenem, anhydrous has been researched along with Cystic Fibrosis of Pancreas in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (20.51) | 18.7374 |
1990's | 10 (25.64) | 18.2507 |
2000's | 7 (17.95) | 29.6817 |
2010's | 11 (28.21) | 24.3611 |
2020's | 3 (7.69) | 2.80 |
Authors | Studies |
---|---|
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J | 1 |
Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL | 1 |
Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
Bottery, MJ; Friman, VP; Quinn, AM; Thompson, H | 1 |
Dargahi, Z; Etemad, A; Ghasemian, E; Hashemian, M; Kaviar, VH; Lohrasbi, A; Saadh, MJ | 1 |
Belz, DC; Deck, DH; Ignatius, EH; Lamichhane, G; Lippincott, CK; Nicklas, DA; Panthi, CM; Rimal, B; Serio, AW | 1 |
Caspar, Y; Courtois, N; Maurin, M | 1 |
Abdalhamid, B; Fowler, RC; Hanson, ND; Harrison, LB; Selmecki, A | 1 |
Bellulo, S; Degand, N; Diene, SM; Dubus, JC; L'homme, T; Leroy, S; Mely, L; Rolain, JM; Stremler, N | 1 |
Arthur, M; Dubée, V; Gaillard, JL; Gutmann, L; Herrmann, JL; Heym, B; Lavollay, M; Mainardi, JL | 1 |
Al-Mathkhury, HJ; Kuchma, SL; Musafer, HK; Naimie, AA; O'Toole, GA; Schwartzman, JD | 1 |
Diene, SM; Gupta, SK; Rolain, JM; Sharma, P | 1 |
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Maitte, A; Potel, G | 1 |
Girlich, D; Kolb, A; Naas, T; Nordmann, P | 1 |
Baquero, F; Cantón, R; del Campo, R; García-Castillo, M; Morosini, MI; Turrientes, MC; Zamora, J | 1 |
Barbeito Castiñeiras, G; Martín Romero Domínguez, M; Martínez-Lamas, L; Palacios Bartolomé, A; Pérez Del Molino Bernal, ML; Rabade Castedo, C | 1 |
Arıkan Ayyıldız, Z; Bahar, IH; Fırıncı, F; Karaman, M | 1 |
Jones, RN; Mutnick, AH; Turner, PJ | 1 |
Kadry, AA | 1 |
Neu, HC; Prince, AS | 1 |
Ballestero, S; Baquero, F; Escobar, H; Fernández-Rodríguez, A; Pérez-Díaz, JC; Villaverde, R | 1 |
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
Christenson, JC; Daly, JA; Korgenski, EK | 1 |
Bingen, E; Bonacorsi, S; Brahimi, N; Gérardin, M; Lebourgeois, M; Mariani-Kurkdjian, P; Munck, A; Navarro, J | 1 |
Dotti, M; Giacchino, M; Pavesio, D; Pecco, P | 1 |
Dyke, JW; Hay, MB; Kumar, A; Maier, GA | 1 |
Bingen, E; Denamur, E; Elion, J; Foucaud, P; Goullet, P; Lambert-Zechovsky, N; Navarro, J; Picard, B | 1 |
Godard, C; Leroy, J; Michel-Briand, Y | 1 |
Croizé, J; Hirtz, P; Le Noc, P; Recule, C | 1 |
Greene, LM; Harwood, IR; Kozakowski-Koch, JA; Rasor, JS | 1 |
Goldmann, DA; Lambert, KG; Macone, AB; O'Rourke, EJ; Parsonnet, KC | 1 |
Ansorg, R; Müller, KD; Wiora, J | 1 |
McCracken, GH; Mustafa, MM | 1 |
Gordon, RC; Kumar, A; Wofford-McQueen, R | 1 |
Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT | 1 |
Bergan, T; Malmborg, AS; Michalsen, H; Storrøsten, OT; Strandvik, B; Wretlind, B | 1 |
Agueda, L; Chabanon, G; Dournes, JL; Lapchine, L; Marty, N | 1 |
Blumer, JL; Myers, CM; O'Brien, CA; Reed, MD; Stern, RC; Yamashita, TS | 1 |
Bentzon, MW; Høiby, N; Koch, C; Pedersen, SS; Pressler, T | 1 |
2 review(s) available for imipenem, anhydrous and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2022 |
Antimicrobial agents in pediatrics.
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Child; Child, Preschool; Cilastatin; Cystic Fibrosis; Humans; Imipenem; Infant; Tissue Distribution | 1989 |
1 trial(s) available for imipenem, anhydrous and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.
Topics: Adolescent; Adult; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Imipenem; Infant; Infant, Newborn; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Species Specificity; Thienamycins | 1996 |
36 other study(ies) available for imipenem, anhydrous and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests | 2007 |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors | 2009 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine | 2022 |
Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cystic Fibrosis; Imipenem; Linezolid; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Rifabutin; Tetracyclines | 2023 |
Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporinase; Cloxacillin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; France; Humans; Imipenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2018 |
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Cell Membrane; Codon, Nonsense; Cystic Fibrosis; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Mutation, Missense; Permeability; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Whole Genome Sequencing | 2019 |
ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; DNA Transposable Elements; Drug Resistance, Bacterial; Female; France; Gene Expression Regulation, Bacterial; Humans; Imipenem; Inverted Repeat Sequences; Microbial Sensitivity Tests; Molecular Sequence Data; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2013 |
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex.
Topics: Anti-Bacterial Agents; Cefoxitin; Colony Count, Microbial; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Respiratory Tract Infections | 2014 |
Investigating the link between imipenem resistance and biofilm formation by Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; Mutation; Porins; Pseudomonas aeruginosa; Sputum | 2014 |
Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; beta-Lactamases; Chryseobacterium; Colistin; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; France; Humans; Imipenem; Mutation; Phylogeny; Sequence Analysis, DNA | 2015 |
MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2016 |
Characterization of regulatory element Rp3 of regulation of beta-lactamases from Ralstonia pickettii.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cystic Fibrosis; DNA, Bacterial; Gene Expression Regulation, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Molecular Sequence Data; Promoter Regions, Genetic; Ralstonia pickettii; Transcription Factors; Transcription Initiation Site; Transcriptional Activation | 2009 |
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Biofilms; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Bacterial; Genetic Variation; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Tobramycin | 2011 |
[Pandoraea sputorum colonization in a patient with cystic fibrosis].
Topics: Anti-Bacterial Agents; Bronchiectasis; Burkholderia cepacia complex; Burkholderia Infections; Child; Cystic Fibrosis; Cytokines; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Imipenem; Pneumonia, Bacterial; Pseudomonas Infections; Sputum; Superinfection; Virulence | 2011 |
[Effects of Imipenem, Tobramycin and Curcumin on Biofilm Formation of Pseudomonas aeruginosa Strains].
Topics: Anti-Bacterial Agents; Biofilms; Curcumin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2013 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins | 2002 |
Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Cefepime; Ceftazidime; Ceftriaxone; Cell Membrane Permeability; Cephalosporins; Conjugation, Genetic; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Humans; Imipenem; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa | 2003 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 2000 |
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.
Topics: Administration, Inhalation; Administration, Oral; Ceftazidime; Child; Child, Preschool; Chronic Disease; Colistin; Colony Count, Microbial; Cystic Fibrosis; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infant; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Tobramycin | 2001 |
Imipenem use in serious childhood infections.
Topics: Antineoplastic Agents; Bacterial Infections; Child; Cystic Fibrosis; Humans; Imipenem; Neoplasms; Neutropenia; Retrospective Studies; Surgical Wound Infection; Thienamycins; Treatment Outcome | 1991 |
Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
Topics: Burkholderia cepacia; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1992 |
Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.
Topics: Azlocillin; Bacterial Typing Techniques; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Esterases; Humans; Imipenem; Polymorphism, Restriction Fragment Length; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1992 |
Characterization of imipenem-resistant Pseudomonas aeruginosa strains from cystic fibrosis patients.
Topics: Cilastatin; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Pseudomonas aeruginosa | 1992 |
[Pseudomonas aeruginosa and imipenem: correlation between membrane protein D2 and resistance in fifteen strains isolated from patients with mucoviscidosis].
Topics: Bacterial Outer Membrane Proteins; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; In Vitro Techniques; Molecular Weight; Pseudomonas aeruginosa; Pseudomonas Infections | 1992 |
New peripherally inserted midline catheter: a better alternative for intravenous antibiotic therapy in patients with cystic fibrosis.
Topics: Adolescent; Adult; Catheterization, Peripheral; Catheters, Indwelling; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Elbow; Female; Humans; Imipenem; Infusions, Intravenous; Male; Piperacillin; Time Factors; Tobramycin | 1992 |
False resistance to imipenem with a microdilution susceptibility testing system.
Topics: Cystic Fibrosis; Drug Resistance, Microbial; Escherichia coli; False Positive Reactions; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Sensitivity and Specificity | 1991 |
Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Amikacin; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1990 |
Ciprofloxacin, imipenem and rifampicin: in-vitro synergy of two and three drug combinations against Pseudomonas cepacia.
Topics: Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Rifampin; Sputum | 1989 |
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin | 1987 |
Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis.
Topics: Adolescent; Adult; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins | 1988 |
Effects of five antibiotics on adhesion and haemagglutinating properties of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Cefsulodin; Ceftazidime; Cystic Fibrosis; Guinea Pigs; Hemagglutination; Humans; Imipenem; Microscopy, Electron; Moxalactam; Pefloxacin; Pseudomonas aeruginosa; Sputum | 1988 |
Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Child; Chromatography, High Pressure Liquid; Cilastatin; Creatinine; Cyclopropanes; Cystic Fibrosis; Dipeptidases; Drug Combinations; Humans; Imipenem; Kinetics; Thienamycins | 1985 |
Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.
Topics: Adolescent; Adult; Child; Cilastatin; Cyclopropanes; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1985 |